Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?

J Gastroenterol. 2004 Dec;39(12):1228-9. doi: 10.1007/s00535-004-1508-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / biosynthesis
  • Carcinoma, Hepatocellular / chemistry*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / metabolism
  • Cisplatin / therapeutic use*
  • Humans
  • Liver Neoplasms / chemistry*
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / metabolism
  • Metallothionein / analysis*
  • Metallothionein / biosynthesis
  • Patient Selection

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Metallothionein
  • Cisplatin